SKYSTAR BIO-PHARMACEUTICAL CO — key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2013)

$42.5M

Net Income/Loss (FY2013)

$10.5M

Total Assets (FY2013)

$136.2M

Total Equity (FY2013)

$110.4M

Cash Flows from Operating Activities (FY2013)

-$5.4M

Source: SKYSTAR BIO-PHARMACEUTICAL CO 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.